Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference32 articles.
1. Triple-negative breast cancer;Foulkes;N Engl J Med,2010
2. ERbeta decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function;Bado;Oncotarget,2016
3. Targeting triple negative breast cancer: is p53 the answer?;Turner;Cancer Treat Rev,2013
4. Intratumor heterogeneity predicts metastasis of triple-negative breast cancer;Yang;Carcinogenesis,2017
5. Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1;Aarts;Cancer Discov,2012
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Seize the engine: Emerging cell cycle targets in breast cancer;Clinical and Translational Medicine;2024-01
2. Adavosertib and beyond: Biomarkers, drug combination and toxicity of WEE1 inhibitors;Critical Reviews in Oncology/Hematology;2024-01
3. Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment;Molecules;2023-11-09
4. Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders;ACS Omega;2023-06-02
5. Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process;Cells;2023-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3